The hip replacement implants market has seen considerable growth due to a variety of factors.
• The market size for hip replacement implants has seen robust expansion in the last few years, increasing from $7.94 billion in 2024 to $8.49 billion in 2025 with a compound annual growth rate (CAGR) of 6.9%. Factors contributing to this consistent growth include an aging population, a rise in the occurrence of osteoarthritis, an increase in hip fractures and trauma cases, individual preference for improved mobility, an international rise in obesity, and a surge in sports-related hip injuries.
The Hip Replacement Implants market is expected to maintain its strong growth trajectory in upcoming years.
• In the following years, a substantial surge is anticipated in the hip replacement implants market, projecting to expand to $11.8 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.6%.
The impending growth during the predicted period can be credited to the escalating demand for outpatient hip replacements, advancements in implant materials, worldwide initiatives towards arthritis awareness, regulatory endorsement for innovation, and environmental sustainability in the healthcare field. Predominant trends anticipated during the forecast period encompass technological progression, personalized implants, robot-assisted surgical procedures, outcome data evaluation and value-based care, tailored implant alternatives, as well as advancements in telemedicine and remote consultations.
The growth of the hip replacement implant market is anticipated to be powered by a rise in the incidence of arthritis. Arthritis constitutes the inflammation and soreness of one or more joints, resulting in intense bone and joint pain. Osteoarthritis and rheumatoid arthritis are frequent forms of arthritis. Hip replacement implants are typically used in hip replacement procedures or hip arthroplasty to mitigate hip discomfort and revive its function by substituting damaged or dysfunctional parts of the hip with artificial implants. As reported by the Centers for Disease Control and Prevention, a national public health agency in the US, in February 2024, about 18.9% of adults were diagnosed with arthritis in 2022, with women (21.5%) having a higher incidence than men (16.1%). The prevalence escalated with age, ranging from 3.6% in adults aged 18-34 to 53.9% in individuals aged 75 and above. Therefore, the soaring incidence of arthritis is fuelling the expansion of the hip replacement implant market.
The hip replacement implants market covered in this report is segmented –
1) By Product Type: Femoral Reconstruction, Acetabular Reconstruction, Hip Resurfacing, Revision Hip Implants, Bearing And Porous Metal, Total Replacement Implants
2) By Component: Ace Tabular Cup Systems, Hip Stem Systems, Revision Accessories And Components
3) By Material: Metal-On-Metal, Metal-On-Polyethylene, Ceramic-On-Metal, Ceramic-On-Polyethylene, Ceramic-On-Ceramic
4) By End-User: Orthopedic Clinics, Hospitals, Surgical Centers
Subsegments:
1) By Femoral Reconstruction: Femoral Heads, Femoral Stems
2) By Acetabular Reconstruction: Acetabular Cups, Acetabular Liners
3) By Hip Resurfacing: Resurfacing Implants, Resurfacing Instruments
4) By Revision Hip Implants: Revision Femoral Components, Revision Acetabular Components
5) By Bearing And Porous Metal: Ceramic Bearings, Metal Bearings, Polyethylene Bearings, Porous Metal Implants
6) By Total Replacement Implants: Total Hip Arthroplasty (THA) Implants, Minimally Invasive Implants
The advancement of technology is an emerging trend in the hip replacement implant market, with major companies investing heavily in research and development of innovative technologies to bolster their market position. For example, in June 2022, InssTek Inc., a prominent South Korean metal 3D printing firm in the additive manufacturing sector, unveiled its Metal Porous Coating (MPC) technology. This innovative technology aims to coat and construct artificial hip joint and cup components, aiming to make surgeries more precise and faster, especially when it comes to titanium materials. The MPC technique, which is essentially a direct energy deposition (DED) additive manufacturing methodology, allows for 3D printing patterns of porous structures onto the surface of artificial joints using medical-grade titanium powder. With this, it creates a single alloy to deliver optimal roughness and pore structure, facilitating more accurate surgeries with maximum biocompatibility, especially when working with titanium materials. The company successfully coated a BENCOX Mirabo Z Cup Cortinium artificial hip joint cup using MPC technology. This product, developed by Korean artificial limb creator Corentec, also has FDA approval.
Major companies operating in the hip replacement implants market include:
• Zimmer Biomet Holdings Inc.
• DePuy Synthes
• Stryker Corporation
• Smith & Nephew PLC
• B Braun SE
• Corin Group PLC.
• Waldemar Link GmbH & Co KG
• Wright Medical Group NV
• Arthrex Inc.
• Corentec Co Ltd.
• MicroPort Scientific Corporation
• Exactech Inc.
• DJO Global Inc.
• OMNI life science Inc.
• Integra LifeSciences Holdings Corporation
• Medacta International SA
• PETER BREHM GmbH
• Gruppo Bioimpianti srl.
• Globus Medical Inc.
• Enovis Medical
• Kyocera Corporation
• Merete GmbH
• Ortho Development Corporation
• Shanghai MicroPort Orthopedics Inc.
• FH Orthopedics Inc.
• LimaCorporate SPA
• Mathys AG Bettlach
• ConforMIS Inc.
• AK Medical Holdings Limited
• Beijing Chunlizhengda Medical Instruments Co. Ltd.
North America was the largest region in the hip replacement implants market in 2024. Asia-Pacific is expected to be the fastest-growing region in the hip replacement implants market during the forecast period. The regions covered in the hip replacement implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa